Global Pharmaceuticals Industry
- All
- News
-
Rising Cybersecurity Attacks Highlight Vulnerabilities of Indian Companies as They Digitise Operations
A rise in cyberattacks poses a vital risk to India’s economic ambitions, with industries from manufacturing to pharmaceuticals becoming more vulnerable as they digitise operations, according to Google Cloud. Attacks have spiked significantly in the past six months, said Amit Pradhan, India consulting leader for the cybersecurity firm Mandiant.
-
Not Without India: World's Pharmacy Gears Up For COVID-19 Vaccine Race
India, the world's biggest vaccine maker, is getting set for the massive global blitz to contain the coronavirus pandemic with its pharmaceutical industry and partners freeing up capacity and accelerating investments even without firm purchase orders.
-
Indian Pharma Is Scaling Up Vaccine Plans For Local and Global Needs
India, the world's biggest vaccine maker, is getting set for the massive global blitz to contain the coronavirus pandemic with its pharmaceutical industry and partners freeing up capacity and accelerating investments even without firm purchase orders.
-
"10 Covid Vaccines Likely By 2021 Summer": Global Pharma Group Head
Ten COVID-19 vaccines could be available by the middle of next year if they win regulatory approval, but their inventors need patent protection, the head of the global pharmaceutical industry group said on Friday.
-
Blog: I Circled The World In 37 Hours Because Of The Coronavirus
As the global death toll from the coronavirus exceeds 490, with more than 20,600 confirmed cases worldwide, and governments join with pharmaceutical companies to rush to test antiviral treatments, here is a window into how the travel industry operates in the face of a possible pandemic.
-
Nifty Slides Below 11,300 For First Time In Nearly Two Months: 10 Things To Know
Domestic stock markets started Thursday's session on a lower note, with the Nifty slipping below the 11,300 mark for the first time since March 13, tracking weakness in Asian peers where equities dropped to six-week lows on fresh concerns about global growth. The S&P BSE Sensex fell as much as 224.26 points to 37,564.87, and the Nifty moved to 11,2...
-
Sensex Breaks Two-Day Rising Streak, Nifty Settles At 10,767. 10 Points To Know
The S&P BSE Sensex on Friday were 19.41 points down and closed at 35,443.67. The National Stock Exchange (NSE) benchmark index Nifty50 settled at 10,767.65. Stock markets edged lower today after two straight sessions of gains. Markets witnessed a volatile trading during the day. Stock markets largely ended flat as losses in both indexes on account...
-
Government May Consider Import Duty Hike On Some Medical Devices
India has achieved a major global position in the pharmaceutical sector. However, the same has not beenreplicated in the medical devices industry.
-
Indian Pharma Eyes Pride Of Place, Regulation Achilles Heel
The $32-billion generic-driven Indian pharma industry is eyeing a sea of opportunities as global demand for safe and quality drugs rises.
-
Global Pharma Growth Seen Steady In 12-18 Months: Moody's
Global pharmaceutical industry will see an annual earnings growth of 3-4 per cent over the next 12-18 months as solid underlying fundamentals mitigate the effect of the strong US dollar and increasing scrutiny of drug prices, said Moody's Investors Service.
-
Sun Pharma Recalls 3.8 Lakh Cartons of Osteoporosis Drug in US: Report
Around 3.8 lakh cartons of an osteoporosis drug manufactured by domestic drug major Sun Pharmaceutical Industries are being recalled in the US and Puerto Rico due to presence of "unknown impurity".
-
Brexit is Wrong Prescription: European Pharma Industry
Britain's departure from the European Union would threaten scientific research and jeopardise the 28-nation bloc's system of drug regulation, the European pharmaceutical industry said on Wednesday.
-
Sun Pharma Eyes Expansion of Global Consumer Healthcare Space
Pharmaceutical major Sun Pharma is looking to expand its business in the global consumer healthcare space and is not averse to acquiring new brands, a top company executive said on Tuesday.
-
Sun Pharma Investors Approve Amalgamation Scheme
Sun Pharmaceutical on Friday said its shareholders have in a court convened meeting approved the scheme of amalgamation of Sun Pharma Global Inc with itself.
-
Sun Pharma Recalls 5,322 Bottles of Ketorolac Eye Drop in US
As per the information available on the USFDA website, Sun Pharma Global Fze, a US-based unit of the company, is recalling the eye drops for "presence of particulate matter" in the 5,322 batch of bottles.
-
Rising Cybersecurity Attacks Highlight Vulnerabilities of Indian Companies as They Digitise Operations
A rise in cyberattacks poses a vital risk to India’s economic ambitions, with industries from manufacturing to pharmaceuticals becoming more vulnerable as they digitise operations, according to Google Cloud. Attacks have spiked significantly in the past six months, said Amit Pradhan, India consulting leader for the cybersecurity firm Mandiant.
-
Not Without India: World's Pharmacy Gears Up For COVID-19 Vaccine Race
India, the world's biggest vaccine maker, is getting set for the massive global blitz to contain the coronavirus pandemic with its pharmaceutical industry and partners freeing up capacity and accelerating investments even without firm purchase orders.
-
Indian Pharma Is Scaling Up Vaccine Plans For Local and Global Needs
India, the world's biggest vaccine maker, is getting set for the massive global blitz to contain the coronavirus pandemic with its pharmaceutical industry and partners freeing up capacity and accelerating investments even without firm purchase orders.
-
"10 Covid Vaccines Likely By 2021 Summer": Global Pharma Group Head
Ten COVID-19 vaccines could be available by the middle of next year if they win regulatory approval, but their inventors need patent protection, the head of the global pharmaceutical industry group said on Friday.
-
Blog: I Circled The World In 37 Hours Because Of The Coronavirus
As the global death toll from the coronavirus exceeds 490, with more than 20,600 confirmed cases worldwide, and governments join with pharmaceutical companies to rush to test antiviral treatments, here is a window into how the travel industry operates in the face of a possible pandemic.
-
Nifty Slides Below 11,300 For First Time In Nearly Two Months: 10 Things To Know
Domestic stock markets started Thursday's session on a lower note, with the Nifty slipping below the 11,300 mark for the first time since March 13, tracking weakness in Asian peers where equities dropped to six-week lows on fresh concerns about global growth. The S&P BSE Sensex fell as much as 224.26 points to 37,564.87, and the Nifty moved to 11,2...
-
Sensex Breaks Two-Day Rising Streak, Nifty Settles At 10,767. 10 Points To Know
The S&P BSE Sensex on Friday were 19.41 points down and closed at 35,443.67. The National Stock Exchange (NSE) benchmark index Nifty50 settled at 10,767.65. Stock markets edged lower today after two straight sessions of gains. Markets witnessed a volatile trading during the day. Stock markets largely ended flat as losses in both indexes on account...
-
Government May Consider Import Duty Hike On Some Medical Devices
India has achieved a major global position in the pharmaceutical sector. However, the same has not beenreplicated in the medical devices industry.
-
Indian Pharma Eyes Pride Of Place, Regulation Achilles Heel
The $32-billion generic-driven Indian pharma industry is eyeing a sea of opportunities as global demand for safe and quality drugs rises.
-
Global Pharma Growth Seen Steady In 12-18 Months: Moody's
Global pharmaceutical industry will see an annual earnings growth of 3-4 per cent over the next 12-18 months as solid underlying fundamentals mitigate the effect of the strong US dollar and increasing scrutiny of drug prices, said Moody's Investors Service.
-
Sun Pharma Recalls 3.8 Lakh Cartons of Osteoporosis Drug in US: Report
Around 3.8 lakh cartons of an osteoporosis drug manufactured by domestic drug major Sun Pharmaceutical Industries are being recalled in the US and Puerto Rico due to presence of "unknown impurity".
-
Brexit is Wrong Prescription: European Pharma Industry
Britain's departure from the European Union would threaten scientific research and jeopardise the 28-nation bloc's system of drug regulation, the European pharmaceutical industry said on Wednesday.
-
Sun Pharma Eyes Expansion of Global Consumer Healthcare Space
Pharmaceutical major Sun Pharma is looking to expand its business in the global consumer healthcare space and is not averse to acquiring new brands, a top company executive said on Tuesday.
-
Sun Pharma Investors Approve Amalgamation Scheme
Sun Pharmaceutical on Friday said its shareholders have in a court convened meeting approved the scheme of amalgamation of Sun Pharma Global Inc with itself.
-
Sun Pharma Recalls 5,322 Bottles of Ketorolac Eye Drop in US
As per the information available on the USFDA website, Sun Pharma Global Fze, a US-based unit of the company, is recalling the eye drops for "presence of particulate matter" in the 5,322 batch of bottles.
